These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8777065)

  • 1. A combined community strategy to reduce cholesterol and other risk factors.
    Sperber AD; Galil A; Sarov B; Stahl Z; Shany S
    Am J Prev Med; 1996; 12(2):123-8. PubMed ID: 8777065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A public health approach to cholesterol. Confronting the 'TV-auto-supermarket society'.
    Bodenheimer T
    West J Med; 1991 Mar; 154(3):344-8. PubMed ID: 2028608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a community-based coronary risk reduction: the Rockford CHIP.
    Englert HS; Diehl HA; Greenlaw RL; Willich SN; Aldana S
    Prev Med; 2007 Jun; 44(6):513-9. PubMed ID: 17383717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a sustainable community intervention reduce the health gap?--10-year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease.
    Weinehall L; Hellsten G; Boman K; Hallmans G; Asplund K; Wall S
    Scand J Public Health Suppl; 2001; 56():59-68. PubMed ID: 11681565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk for coronary heart disease in Thiruvananthapuram city: a study of serum lipids and other risk factors.
    Joseph A; Kutty VR; Soman CR
    Indian Heart J; 2000; 52(1):29-35. PubMed ID: 10820930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
    Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
    Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A video-based lifestyle intervention and changes in coronary risk.
    Aldana SG; Greenlaw RL; Diehl HA; Merrill RM; Salberg A; Englert H
    Health Educ Res; 2008 Feb; 23(1):115-24. PubMed ID: 17347525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting physical activity in a low-income multiethnic district: effects of a community intervention study to reduce risk factors for type 2 diabetes and cardiovascular disease: a community intervention reducing inactivity.
    Jenum AK; Anderssen SA; Birkeland KI; Holme I; Graff-Iversen S; Lorentzen C; Ommundsen Y; Raastad T; Odegaard AK; Bahr R
    Diabetes Care; 2006 Jul; 29(7):1605-12. PubMed ID: 16801586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive strategies for reducing coronary heart disease-related morbidity and mortality in patients with multiple risk factors.
    Brown WV
    J Am Osteopath Assoc; 2001 Sep; 101(9 Suppl):S6-11. PubMed ID: 11575043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5-year community intervention Hartslag Limburg on cardiovascular risk factors.
    Schuit AJ; Wendel-Vos GC; Verschuren WM; Ronckers ET; Ament A; Van Assema P; Van Ree J; Ruland EC
    Am J Prev Med; 2006 Mar; 30(3):237-42. PubMed ID: 16476640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid abnormalities in coronary heart disease: a population-based case-control study.
    Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP
    Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein cholesterol goal attainment among high-risk patients: Does a combined intervention targeting patients and providers work?
    Afonso NM; Nassif G; Aranha AN; Delor B; Cardozo LJ
    Am J Manag Care; 2006 Oct; 12(10):589-94. PubMed ID: 17026413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Otsego-Schoharie healthy heart program: prevention of cardiovascular disease in the rural US.
    Nafziger AN; Erb TA; Jenkins PL; Lewis C; Pearson TA
    Scand J Public Health Suppl; 2001; 56():21-32. PubMed ID: 11681560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high-risk and population strategy for occupational health promotion (HIPOP-OHP) study: study design and cardiovascular risk factors at the baseline survey.
    Okamura T; Tanaka T; Babazono A; Yoshita K; Chiba N; Takebayashi T; Nakagawa H; Yamato H; Miura K; Tamaki J; Kadowaki T; Okayama A; Ueshima H;
    J Hum Hypertens; 2004 Jul; 18(7):475-85. PubMed ID: 14749712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.